Cargando…
Anti-Tumor Efficacy of In Situ Vaccination Using Bacterial Outer Membrane Vesicles
SIMPLE SUMMARY: In situ vaccination (ISV) envisages the intratumoral injection of immunostimulatory molecules, which inflame the tumor and induce anti-tumor immune responses. Since bacterial outer membrane vesicles (OMVs) are naturally decorated with components which stimulate innate immunity, we te...
Autores principales: | Caproni, Elena, Corbellari, Riccardo, Tomasi, Michele, Isaac, Samine J., Tamburini, Silvia, Zanella, Ilaria, Grigolato, Martina, Gagliardi, Assunta, Benedet, Mattia, Baraldi, Chiara, Croia, Lorenzo, Di Lascio, Gabriele, Berti, Alvise, Valensin, Silvia, Bellini, Erika, Parri, Matteo, Grandi, Alberto, Grandi, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340493/ https://www.ncbi.nlm.nih.gov/pubmed/37444437 http://dx.doi.org/10.3390/cancers15133328 |
Ejemplares similares
-
Immunogenicity of Escherichia coli Outer Membrane Vesicles: Elucidation of Humoral Responses against OMV-Associated Antigens
por: Croia, Lorenzo, et al.
Publicado: (2023) -
Bacterial Outer Membrane Vesicles as a Platform for the Development of a Broadly Protective Human Papillomavirus Vaccine Based on the Minor Capsid Protein L2
por: Tamburini, Silvia, et al.
Publicado: (2023) -
Proteome‐minimized outer membrane vesicles from Escherichia coli as a generalized vaccine platform
por: Zanella, Ilaria, et al.
Publicado: (2021) -
Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells
por: Tomasi, Michele, et al.
Publicado: (2022) -
Vaccination With a FAT1-Derived B Cell Epitope Combined With Tumor-Specific B and T Cell Epitopes Elicits Additive Protection in Cancer Mouse Models
por: Grandi, Alberto, et al.
Publicado: (2018)